Key result
Higher pre-procedural systemic immune-inflammation index predicts increased 6-month major cardiovascular events risk after TAVI.
Why the study?
To evaluate whether the systemic immune-inflammation index has prognostic value for major adverse cardiac events and short-term all-cause mortality in aortic stenosis patients undergoing TAVI.
Does the systemic immune-inflammation index (SII) predict major adverse cardiac events and mortality at 6 months in patients with severe aortic stenosis undergoing TAVI?
Cohort (n=120)
No
Does the systemic immune-inflammation index (SII) predict major adverse cardiac events and mortality at 6 months in patients with severe aortic stenosis undergoing TAVI?
A high pre-procedural systemic immune-inflammation index is a strong independent predictor of 6-month MACEs and mortality in patients undergoing TAVI for severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
SII may refine pre-TAVI risk stratification in severe AS; leaves open whether it adds value beyond existing scores in prospective cohorts.
Background and objectives: In this study, we aimed to evaluate whether the systemic immune-inflammation index (SII) has a prognostic value for major adverse cardiac events (MACEs), including stroke, re-hospitalization, and short-term all-cause mortality at 6 months, in aortic stenosis (AS) patients who underwent transcatheter aortic valve implantation (TAVI). Materials and Methods: A total of 120 patients who underwent TAVI due to severe AS were retrospectively included in our study. The main outcome of the study was MACEs and short-term all-cause mortality at 6 months. Results: The SII was found to be higher in TAVI patients who developed MACEs than in those who did not develop them. Multivariate Cox regression analysis revealed that the SII (HR: 1.002, 95%CI: 1.001–1.003, p < 0.01) was an independent predictor of MACEs in AS patients after TAVI. The optimal value of the SII for MACEs in AS patients following TAVI was >1.056 with 94% sensitivity and 96% specificity (AUC (the area under the curve): 0.960, p < 0.01). We noted that the AUC value of SII in predicting MACEs was significantly higher than the AUC value of the C-reactive protein (AUC: 0.960 vs. AUC: 0.714, respectively). Conclusions: This is the first study to show that high pre-procedural SII may have a predictive value for MACEs and short-term mortality in AS patients undergoing TAVI.
No takes yet. Share an insight, caveat, or question.
Tosu et al. (2021) conducted a cohort in Severe aortic stenosis (n=120). Systemic immune-inflammation index (SII) vs. Lower systemic immune-inflammation index was evaluated on Major adverse cardiac events (MACEs) and short-term all-cause mortality at 6 months (HR 1.002, 95% CI 1.001-1.003, p=<0.01). A higher pre-procedural systemic immune-inflammation index independently predicted major adverse cardiac events at 6 months in severe aortic stenosis patients after TAVI.
Synapse has enriched 10 related papers. Consider them for comparative context: